• Date: January 17, 2019

Now that the 20 projects selected in CaixaImpulse 2018 have completed their training, they are currently in the process of implementing the valorisation plans that were approved by the programme’s expert panel on 9 November. The teams behind the projects have 15 months to execute the actions included in their respective plans. These may range from protecting an asset, to developing a minimum viable product, to carrying out further scientific tests.

Likewise, for the next four months, participants can meet with CaixaImpulse’s directory of over 60 experts. As part of the programme, each team can request up to 12 hours of consultancy from the experts in various areas of research transfer to market, such as drug marketing, funding, prototyping and design, licencing and legal issues, and more, bringing the development of each project one step closer.

More programme highlights

February 14, 2019

GlyCardial Diagnostics wins Horizon 2020 funding

Apo J-Glyc, a project selected in CaixaImpulse 2015, is now operating as a company named GlyCardial Diagnostics.

February 12, 2019

“The entrepreneur is the one who has to choose, whether they get it right or make mistakes”

Roger Gomis from IRB talks to us about what CaixaImpulse means to him and explains more about his role as mentor.

February 04, 2019

Applications open for CaixaImpulse’s 2019 call

CaixaImpulse is seeking 25 innovative health and biomedical projects to support and develop starting in 2019.